Table 2 Laboratory Findings on Admission in the Discharged and Death Groups

WBC- × 10⁹/L, median (IQR)

6.3(5.0–8.4)

6.2(5.0–8.1)

8.6(5.2–14.9)

0.064

> 10-no.(%)

18(12.8)

10(8.1)

8(44.4)

0.000

Lymphocyte- × 10⁹/L, median (IQR)

1.2(1.0–1.6)

1.3(1.0–1.6)

1.0(0.7–1.4)

0.010

≤1.1-no. (%)

57(40.4)

44(35.8)

13(72.2)

0.003

Neutrophil- × 10⁹/L, median (IQR)

4.0(3.0–6.2)

3.9(2.9–5.8)

7.2(3.1–13.9)

0.022

> 6.3-no. (%)

34(24.1)

24(19.5)

10(55.6)

0.002

Platelet- × 10⁹/L, median (IQR)

225.0(163.5–296.0)

234.0(172.0–301.0)

134(96.5–217.0)

0.001

≤100-no. (%)

10(7.1)

5(4.1)

5(27.8)

0.002

RBC- × 10¹²/L, median (IQR)

3.9(3.6–4.3)

3.9(3.6–4.3)

3.7(3.0–4.0)

0.023

≤4.0-no. (%)

84(59.6)

70(56.9)

14(77.8)

0.092

Hemoglobin- g/L, median (IQR)

120.0(109.5–130.0)

121.0(111.0–131.0)

112.0(100.0–119.0)

0.009

≤110-no. (%)

38(27.0)

30(24.4)

8(44.4)

0.132

CRP-mg/L, median (IQR)

13.2(3.2–39.1)

9.0(3.1–28.8)

106.0(21.9–150.0)

0.000

> 5.0-no. (%)

100(70.9)

82(66.7)

18(100.0)

0.004

Procalcitonin-ng/L, median (IQR)

40.0(20.0–100.0)

40.0(20.0–70.0)

360.0(97.5–1235.0)

0.000

> 500-no. (%)

9(6.4)

1(0.8)

8(44.4)

0.000

D-dimer-mg/L, median (IQR)

0.9(0.8–3.4)

0.9(0.8–2.7)

3.1(2.1–12.1)

0.000

> 1.0-no. (%)

69(48.9)

52(42.3)

17(94.4)

0.000

Creatinine-μmol/L, median (IQR)

69.0(58.0–98.0)

68.0(57.0–94.0)

96.0(64.3–133.3)

0.026

> 97-no. (%)

36(25.5)

27(22.0)

9(50.0)

0.024

BUN-mmol/L, median (IQR)

6.3(4.4–8.3)

5.4(4.1–7.5)

9.8(6.8–13.6)

0.000

> 7.1-no. (%)

47(33.3)

35(28.5)

12(66.7)

0.001

AST-IU/L, median (IQR)

25.0(20.0–33.5)

24.0(19.0–31.0)

33.0(23.8–55.5)

0.005

> 35-no. (%)

31(22.0)

24(19.5)

7(38.9)

0.121

ALT-IU/L, median (IQR)

19.0(13.0–26.5)

18.0(13.0–27.0)

22.0(13.0–27.3)

0.500

> 45-no. (%)

14(9.9)

14(11.4)

0(0.0)

0.277

LDH- IU/L, median (IQR)

218.0(168.5–327.5)

201.0(160.0–275.0)

485.5(257.3–811.3)

0.000

> 250-no. (%)

51(36.2)

37(30.1)

14(77.8)

0.000

TB-μmol/L, median (IQR)

11.5(9.1–15.7)

11.5(9.1–14.8)

12.5(9.0–18.0)

0.695

> 24-no. (%)

15(10.6)

12(9.8)

3(16.7)

0.632

Hs-TnI-ng/L, median (IQR)

14.0(8.0–25.0)

12.0(7.0–22.0)

41.0(24.8–168.0)

0.000

> 26-no. (%)

31(22.0)

18(14.6)

13(72.2)

0.000

CK-MB-IU/L, median (IQR)

7.0(5.0–11.0)

7.0(5.0–10.0)

8.5(4.8–13.0)

0.205

> 24-no. (%)

4(2.8)

2(1.6)

2(11.1)

0.079

CK-IU/L, median (IQR)

49.0(31.0–77.0)

44.0(30.0–70.0)

95.0(40.3–156.5)

0.010

> 170-no. (%)

11(7.8)

8(6.5)

3(16.7)

0.303

NT-proBNP-ng/L,median (IQR)

290.0(150.8–819.0)

260.0(124.0–512.0)

2362.5(1707.6–2978.3)

0.000

> 1800-no. (%)

21(14.9)

8(6.5)

13(72.2)

0.000

Ground-glass opacity lesions on CT

0.006

 1–2 lung lobes, no. (%)

88(62.4)

82(66.7)

6(33.3)

.

  ≥ 3 lung lobes, no. (%)

53(37.6)

41(33.3)

12(66.7)